CONGENITAL CYTOMEGALOVIRUS INFECTION

CONGENITAL CYTOMEGALOVIRUS INFECTION was reported 170 times

CONGENITAL CYTOMEGALOVIRUS INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 21 0.0009
1 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 41 0.0004
2 Human Immunoglobulin G [EPC] 5 0.0002
3 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 11 0.0002
4 Purine Antimetabolite [EPC] 20 0.0002
5 CD52-directed Cytolytic Antibody [EPC] 3 0.0002
6 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 17 0.0001
7 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 17 0.0001
8 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1 0.0001
9 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
10 Protease Inhibitor [EPC] 4 0.0001
11 Parenteral Iron Replacement [EPC] 1 0.0001
12 CD20-directed Cytolytic Antibody [EPC] 22 0.0001
13 Cytochrome P450 3A Inhibitor [EPC] 4 0.0001
14 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
15 Alkylating Drug [EPC] 16 0.0001
16 Nucleoside Analog Antiviral [EPC] 5 0.0001
17 Antimetabolite Immunosuppressant [EPC] 1 0.0000
18 Corticosteroid [EPC] 40 0.0000
19 Sympathomimetic-like Agent [EPC] 1 0.0000
20 Azole Antifungal [EPC] 3 0.0000
21 Macrolide Antimicrobial [EPC] 1 0.0000
22 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
23 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
24 Fluoroquinolone Antibacterial [EPC] 1 0.0000
25 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
26 Anti-epileptic Agent [EPC] 1 0.0000
27 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
28 Platelet Aggregation Inhibitor [EPC] 2 0.0000
29 beta-Adrenergic Blocker [EPC] 1 0.0000
30 Atypical Antipsychotic [EPC] 1 0.0000
31 Proton Pump Inhibitor [EPC] 1 0.0000
32 Benzodiazepine [EPC] 1 0.0000